Senseonics Holdings Inc (SENS) Sees Large Decrease in Short Interest

Senseonics Holdings Inc (NYSEAMERICAN:SENS) was the recipient of a large decline in short interest in December. As of December 29th, there was short interest totalling 3,864,087 shares, a decline of 5.5% from the December 15th total of 4,088,887 shares. Currently, 8.0% of the shares of the stock are short sold. Based on an average trading volume of 307,944 shares, the short-interest ratio is presently 12.5 days.

Senseonics (NYSEAMERICAN:SENS) opened at $3.13 on Thursday. The firm has a market capitalization of $393.85 and a price-to-earnings ratio of -6.26. The company has a quick ratio of 2.81, a current ratio of 2.93 and a debt-to-equity ratio of 0.76. Senseonics has a fifty-two week low of $1.26 and a fifty-two week high of $3.67.

Senseonics (NYSEAMERICAN:SENS) last posted its quarterly earnings results on Tuesday, October 31st. The company reported ($0.13) EPS for the quarter, hitting analysts’ consensus estimates of ($0.13). Senseonics had a negative return on equity of 406.72% and a negative net margin of 828.76%. The company had revenue of $2.10 million during the quarter, compared to analysts’ expectations of $1.51 million. The company’s revenue for the quarter was up 425.0% compared to the same quarter last year. equities research analysts anticipate that Senseonics will post -0.54 earnings per share for the current fiscal year.

Separately, Canaccord Genuity reaffirmed a “buy” rating on shares of Senseonics in a report on Wednesday, November 1st.

In other Senseonics news, major shareholder Peter J. Barris sold 139,645 shares of Senseonics stock in a transaction on Friday, December 8th. The stock was sold at an average price of $2.63, for a total value of $367,266.35. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 34.10% of the stock is owned by insiders.

Institutional investors have recently bought and sold shares of the company. Goldman Sachs Group Inc. acquired a new position in shares of Senseonics during the 2nd quarter worth $276,000. Raymond James Financial Services Advisors Inc. raised its holdings in shares of Senseonics by 221.4% during the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 263,562 shares of the company’s stock worth $474,000 after buying an additional 181,562 shares in the last quarter. Susquehanna International Group LLP acquired a new position in shares of Senseonics during the 2nd quarter worth $155,000. Citadel Advisors LLC acquired a new position in shares of Senseonics during the 3rd quarter worth $194,000. Finally, Perceptive Advisors LLC acquired a new position in shares of Senseonics during the 3rd quarter worth $160,000. 30.66% of the stock is owned by institutional investors.

WARNING: This piece was originally reported by Markets Daily and is the sole property of of Markets Daily. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The legal version of this piece can be viewed at

Senseonics Company Profile

Senseonics Holdings, Inc is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes.

Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply